Perrigo Nasal Oxymetazoline Spray Recalled for Contaminated Excipient
Perrigo Company PLC is recalling approximately 10,800 bottles of NASAL Maximum Strength No Drip Nasal Spray (Oxymetazoline HCl 0.05%) nationwide due to manufacturing with a contaminated excipient supplied by their ingredient vendor.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II recall by the FDA. The source text does not report any illnesses, injuries, or adverse events—only a manufacturing deviation involving a contaminated excipient. Per the rubric, FDA Class II recalls without reported hospitalization or significant injury reports typically score as 2 (Moderate), and the absence of reported harm indicates a precautionary action.
Plain-English summary
Perrigo Company PLC is recalling NASAL Maximum Strength No Drip Nasal Spray (Oxymetazoline HCl 0.05%, 1 FL Oz / 30 mL bottles, NDC 41250-388-10) distributed nationwide. The recall affects approximately 10,800 bottles from Batch 1FK1164 with expiration date 01/31/2023.
The products were manufactured using a contaminated excipient (inactive ingredient) that was recalled by the supplier. This deviation from good manufacturing practices poses a potential quality and safety concern.
Consumers who have purchased this product should stop using it. Those with questions about the recall should contact their healthcare provider or pharmacist. The product was distributed nationwide by Meijer Distribution, Inc., Grand Rapids, MI.
The recalled product
- Product
- NASAL (OXYMETAZOLINE HCL)
- Brand
- NASAL
- Manufacturer
- Perrigo Company PLC
- Hazard
- contaminated-excipient
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1FK1164
- Exp 01/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NASAL
- ModeratePerrigo Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateNasal Decongestant Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateNasal Oxymetazoline Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateOxymetazoline Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModeratePerrigo Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27